Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of a Point-of-care Device for Rapid Bedside Measurement of Circulating Nucleosome Levels in Critically Ill Patients and Study of Its Relevance to Prognostication

NCT07184593 is registered in ClinicalTrials.gov with Erasme University Hospital as lead sponsor.

NCT NCT07184593
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07184593 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of a Point-of-care Device for Rapid Bedside Measurement of Circulating Nucleosome Levels in Critically Ill Patients and Study of Its Relevance to Prognostication
Lead sponsor
Erasme University Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2028
Enrollment
1,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

acute brain injury, cardiac arrest (ca), cardiogenic shock, pancreatitis, sepsis, septic shock, trauma blunt